ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 155 filers reported holding ANTARES PHARMA INC in Q1 2020. The put-call ratio across all filers is 347.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $293,000 | -45.8% | 71,367 | -52.9% | 0.00% | 0.0% |
| Q4 2021 | $541,000 | -33.9% | 151,606 | -32.6% | 0.00% | -50.0% |
| Q3 2021 | $819,000 | +47.8% | 225,049 | +77.1% | 0.00% | 0.0% |
| Q2 2021 | $554,000 | +808.2% | 127,060 | +728.3% | 0.00% | – |
| Q4 2020 | $61,000 | -11.6% | 15,339 | -40.3% | 0.00% | -100.0% |
| Q3 2020 | $69,000 | -86.2% | 25,700 | -85.8% | 0.00% | -87.5% |
| Q2 2020 | $499,000 | +43.4% | 181,604 | +23.1% | 0.01% | -11.1% |
| Q1 2020 | $348,000 | -73.1% | 147,536 | -46.3% | 0.01% | +12.5% |
| Q4 2019 | $1,292,000 | +1118.9% | 274,853 | +769.5% | 0.01% | +700.0% |
| Q3 2019 | $106,000 | +63.1% | 31,609 | -48.9% | 0.00% | -75.0% |
| Q2 2016 | $65,000 | -5.8% | 61,900 | +7.8% | 0.00% | -50.0% |
| Q4 2015 | $69,000 | – | 57,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |